<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=580450&amp;fmt=gif">

RSS header - this is hidden

clinical trials: the challenge of subject retention

Posted by Neoteryx on Apr 23, 2019 4:20:00 AM

Clinical trials are one of the most important elements in research and modern healthcare. It is through clinical trials that medications are tested and their effectiveness established. Without the trials, it would be challenging to make any modern-day medical breakthroughs.

Read More

Topics: Clinical Trials

blood microsampling in pharma, clinical trials, and drug development: a smarter, simpler future

Posted by Neoteryx on Apr 18, 2019 3:23:00 AM

Those at work and innovating in the realms of clinical trials, drug development, and pharma face the largest challenges of their careers. But they do so armed with some of the finest medical tools ever known to man, empowered by opportunities never imagined before.

Read More

Topics: Clinical Trials, Smarter Healthcare

VAMS™ and AEDs: an exciting new LC-MS/MS method

Posted by Neoteryx on Apr 16, 2019 6:09:00 AM

A microsampling pioneer in Italy has recently developed, validated, and submitted for publication a new LC-MS/MS method for measuring concentrations of a range of antiepileptic drugs (AEDs) using Volumetric Absorptive Microsampling (VAMS™) technology. Dr. Ugo de Grazia and his collaborators at Fondazione IRCCS Istituto Neurologico Carlo Besta Neurological Hospital in Milano have established a useful example for facilitating easier antiepileptic drug monitoring and for dealing extraction difficulties of small drugs on different physical-chemical properties.

Read More

Topics: Smarter Healthcare, Patient Monitoring

clinical trials: the challenge of patient recruitment

Posted by Neoteryx on Apr 10, 2019 8:51:00 AM

Clinical trials require recruitment, retention, and engagement. Recruitment is one of the most challenging factors, and one that must be must overcome if anything good is to be accomplished. Poor recruitment results in trial delays, which can lead to financial loses. Recruitment of too few test subjects also creates the potential for presenting biased results; more test participants are needed in order to present comprehensive and conclusive results. Here is why patient recruitment presents a challenge to the recruiters:

Read More

Topics: Clinical Trials

tomorrow’s clinical trials, today: 5 innovations transforming pharmaceutical development

Posted by Neoteryx on Apr 4, 2019 4:44:00 AM

Clinical trials are arguably the most important phase of the pharmaceutical development process; scientists get to see how their drugs work in real life and make important improvements. There are many recent innovations in the medical field that are completely transforming the way we conduct clinical trials, which means important new drugs are safer and get to the market faster. Here are five of the most important innovations that are changing clinical trials today:

Read More

Topics: Clinical Trials

pk monitoring: drugs with a narrow therapeutic index

Posted by Neoteryx on Mar 27, 2019 2:58:00 AM


Patient monitoring is always an important part of the medical process, but it’s particularly crucial when patients are using drugs with a narrow therapeutic index. Drugs with a narrow therapeutic index are drugs in which the dosage must be exact; otherwise, it could lead to serious negative reactions, failures, or dependency. Regular therapeutic drug monitoring is very important for patients taking these drugs.
Read More

Topics: Clinical Research, Smarter Healthcare, Patient Monitoring